BORIS-mediated generation of circular RNAs induces inflammation

• DOI: 10.1016/j.tranon.2022.101363
• Publication Date: 2022-02-16T06:55:15Z
• Authors: Hao Xu; Mengdie Fang; Chao Li; Bowen Zuo; Juan Ren; Yanmei Zhang
• Keywords: 0301 basic medicine; 03 medical and health sciences; BORIS; inflammation; RNA and DNA binding motif; circRNA vaccine; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; Circular RNA; RC254-282; Original Research; 3. Good health

Circular RNAs (circRNAs), which are more stable than linear mRNAs and long non-coding RNAs (LncRNAs), are detected in body fluids such as plasma, serum, and exosomes. Disease-associated circRNAs have significant clinical roles due to their diagnostic and prognostic values. Brother of regulator of imprinting site (BORIS) promotes cancer progression and is specifically highly expressed in the majority of carcinoma. However, the mechanism underlying the regulation of circRNAs by the oncoprotein BORIS and their role in regulating inflammation and immunity remain to be further explored. Vaccines prepared from circRNAs extracted from cancer cells showed that circRNAs induced inflammation and prevented cancer progression. Serum from animals injected with cancer cell-derived circRNAs vigorously reacted with cells that expressed cancer-specific antigen BORIS or cancer extracted circRNAs. It has been implicated that cancer-related circRNAs could be used as antigens to activate immune responses to prevent cancers and stimulate NF-κB signaling pathway by up-regulating and inducing TLR3. In the study we also found that BORIS regulated the expression of circRNAs and interacted with RNA motifs and the CCCTC binding factor (CTCF) motif adjacent to circRNA splicing sites to enhance the formation of circRNAs. Thus, our study delineated the novel mechanism by which cancer-specific antigen BORIS regulated circRNAs and identified that circRNAs could serve as a vaccine for cancer prevention.